|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/07/16 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/07/16 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 08/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/2004 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 24/08/2016 | |
| Director/Board Member | 58 | 24/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.08% | -1.01% | +48.62% | +173.29% | 1,060B | |
| +0.24% | -0.71% | +64.19% | +62.14% | 619B | |
| -0.73% | -3.35% | +28.57% | +84.32% | 438B | |
| -0.73% | +0.69% | +29.65% | +24.85% | 333B | |
| +0.27% | -0.37% | +29.25% | +47.33% | 282B | |
| -1.36% | -10.10% | +18.89% | +22.71% | 267B | |
| +0.67% | +1.20% | -26.69% | -37.86% | 218B | |
| -1.83% | -2.39% | +20.42% | +57.12% | 196B | |
| +0.41% | +0.61% | +16.34% | +69.99% | 161B | |
| Average | -0.33% | -3.33% | +25.47% | +55.99% | 397.1B | |
| Weighted average by Cap. | -0.21% | -3.10% | +35.74% | +84.21% |
- Stock Market
- Stocks
- Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
